Stock Fundamentals

Company Information

Company Name
10X Genomics Inc
Sector
Healthcare
Industry
Health Information Services
Exchange
NASDAQ
ISIN: US88025U1097
CIK: 0001770787
CUSIP: 88025U109
Currency: USD
Full Time Employees: 1,178
Phone: 925 401 7300
Fiscal Year End: December
IPO Date: Sep 12, 2019
Description:

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Address:

6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260

Directors & Officers

Name Title Year Born
Dr. Serge Saxonov Ph.D. Co-Founder, CEO & Director 1977
Dr. Benjamin J. Hindson Ph.D. Co-Founder, President, Chief Scientific Officer & Director 1975
Mr. Adam S. Taich CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer 1975
Mr. Jim Goodrich Chief of Global Operations NA
Mr. Michael Schnall-Levin Ph.D. Founding Scientist & CTO NA
Ms. Cassie Corneau Manager of Investor Relations & Strategic Finance NA
Dr. Randy Wu General Counsel and Secretary NA
Ms. Mennah Moustafa Chief Commercial Officer NA
Mr. Jens Durruthy Associate Director of Product Management NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 14, 2026 Serge Saxonov N/A Sale 5.00K $24.56 $122.80K
Mar 24, 2026 Serge Saxonov N/A Sale 5.00K $19.52 $97.60K
Mar 23, 2026 Serge Saxonov N/A Sale 10.00K $19.13 $191.30K
Feb 23, 2026 Adam Taich N/A Sale 8.97K $18.58 $166.63K
Feb 23, 2026 Benjamin J Hindson N/A Sale 7.83K $18.58 $145.41K
Feb 23, 2026 Serge Saxonov N/A Sale 9.63K $18.58 $178.96K
Nov 24, 2025 Adam Taich N/A Sale 11.89K $19.00 $225.87K
Nov 24, 2025 Benjamin J Hindson N/A Sale 8.28K $19.00 $157.38K
Nov 24, 2025 Serge Saxonov N/A Sale 13.26K $19.00 $251.96K
Aug 22, 2025 Adam Taich N/A Sale 22.32K $13.79 $307.72K
Aug 22, 2025 Benjamin J Hindson N/A Sale 7.49K $13.79 $103.23K
Aug 22, 2025 Serge Saxonov N/A Sale 9.35K $13.79 $128.91K
May 22, 2025 Adam Taich N/A Sale 4.04K $8.30 $33.57K
May 22, 2025 Benjamin J Hindson N/A Sale 7.49K $8.30 $62.13K
May 22, 2025 Serge Saxonov N/A Sale 9.34K $8.30 $77.55K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 17.74M Mar 31, 2026 13.97% $0.02 48.87%
Vanguard Group Inc 13.02M Dec 31, 2025 10.25% $0.00 -1.93%
ARK Investment Management LLC 11.72M Mar 31, 2026 9.23% $1.93 -7.50%
BlackRock Inc 10.08M Mar 31, 2026 7.94% $0.00 0.65%
Vanguard Portfolio Management, LLC 6.91M Mar 31, 2026 5.45% $0.01 0.00%
Quantinno Capital Management LP 5.41M Mar 31, 2026 4.26% $0.19 15.95%
Vanguard Capital Management, LLC 5.27M Mar 31, 2026 4.15% $0.00 0.00%
Sumitomo Mitsui Trust Group Inc 5.11M Mar 31, 2026 4.03% $0.07 -6.95%
Amova Asset Management Americas, Inc 5.10M Mar 31, 2026 4.02% $1.53 -6.96%
The Goldman Sachs Group Inc 3.97M Mar 31, 2026 3.13% $0.01 28.65%
Geode Capital Management, LLC 2.90M Mar 31, 2026 2.29% $0.00 4.10%
Morgan Stanley - Brokerage Accounts 2.66M Mar 31, 2026 2.09% $0.00 -16.91%
State Street Corp 2.59M Mar 31, 2026 2.04% $0.00 3.04%
AQR Capital Management LLC 2.54M Mar 31, 2026 2.00% $0.02 -1.58%
Jacobs Levy Equity Management, Inc. 2.28M Mar 31, 2026 1.80% $0.20 -13.51%
Casdin Capital, LLC 2.28M Mar 31, 2026 1.79% $3.66 62.50%
Millennium Management LLC 2.07M Mar 31, 2026 1.63% $0.02 66.49%
Dimensional Fund Advisors, Inc. 2.04M Mar 31, 2026 1.61% $0.01 34.62%
Capital World Investors 1.45M Mar 31, 2026 1.14% $0.00 0.00%
T. Rowe Price Investment Management,Inc. 1.28M Mar 31, 2026 1.01% $0.02 -28.71%

Shares Statistics

Shares Outstanding: 116.88M
Shares Float: 114.82M
% Insiders: 166.60%
% Institutions: 11,197.20%
Short % Float: 19.11%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 ARK Innovation ETF 7.02M 5.53% ▲ 2.25% May 31, 2026
2 ARK Disruptive Innovation Full Composite 7.00M 5.52% ▼ 8.90% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 3.76M 2.96% ▲ 0.31% Apr 30, 2026
4 ARK Genomic Revolution 3.05M 2.40% ▼ 3.26% Mar 31, 2026
5 ARK Genomic Revolution ETF 2.90M 2.28% ▼ 0.26% May 31, 2026
6 Amova ARK Disruptive Innovation A USD 2.78M 2.19% ▼ 1.96% Apr 30, 2026
7 Vanguard Small Cap Index 2.71M 2.13% ▼ 0.39% Apr 30, 2026
8 iShares Russell 2000 ETF 2.69M 2.12% ▲ 0.93% May 29, 2026
9 Fidelity Select Medical Tech and Devcs 2.01M 1.59% ▲ 2.31% Apr 30, 2026
10 Fidelity Global Innovators Cl F 1.99M 1.57% ▼ 0.59% Mar 31, 2026

Valuation Metrics

Enterprise Value: $4.97B
Trailing P/E: 0.00
Forward P/E: 714.29

Financial Highlights

Market Cap: $5.42B
EBITDA: $-30.67M
Book Value: $6.24
Earnings/Share: $-0.17
Profit Margin: -3.55%
Operating Margin: -11.30%
ROA (TTM): -4.48%
ROE (TTM): -2.98%
Revenue (TTM): $638.78M
Revenue/Share (TTM): $5.06
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -2.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.46x 0.01x 0.24x N/A 2.81x
2024-12-31 4.97x 0.01x 0.23x -48,639.75x -0.07x
2023-12-31 4.69x 0.02x 0.23x -8,040.27x -0.06x
2022-12-31 4.85x 0.01x 0.22x -352.82x -0.07x
2021-12-31 6.77x 0.01x 0.20x -61.10x -0.21x
2020-12-31 6.56x 0.01x 0.20x -50.73x -0.01x
2019-12-31 7.63x 0.07x 0.31x -9.44x -1.42x
2018-12-31 3.28x -0.13x 2.77x -45.98x -0.28x
2017-12-31 3.08x -0.09x 2.49x -22.66x -0.77x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TXG.US!